Mechanistic investigations revealed that VPA simultaneously down-regulates EGFR, ErbB2 and ErbB3 likely via induction of several critical miRNAs in pancreatic cancer cells, and thereby results in inactivation of downstream Akt and MAPK signaling pathways and induces cell apoptosis and growth arrest. The gene discussed is EGFR; the disease is pancreatic neoplasm.